long term Effect of the antiplatelet therapy on ischemic stroke
Phase 4
- Conditions
- cerebral infarction except cardioembolic cerebral embolism
- Registration Number
- JPRN-UMIN000002681
- Lead Sponsor
- eurosurgery, Tokushima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. hemorrhage of hemorrhagic tendenncy 2. indicatied for fibrinokytis therapy using t-PA 3. unable to take antiplatelets 4. allergy for antiplatelets using in this study 5. conttraindicated for drugs using in this study 6. bed ridden state or no expectancy to improve activity of daily life 7. transient ischemic attack 8. other taking drugs are contraindicated to take with antiplatelets using in this study 9. patients enrolled in other clinical trial 10. patients who are assessed inappropriate to enroll in this study by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method